The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 07, 2021
Filed:
Oct. 11, 2016
Applicant:
Isifer Ab, Danderyd, SE;
Inventor:
Jack Spira, Tyresö, SE;
Assignee:
ISIFER AB, Danderyd, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/42 (2017.01); A61K 9/08 (2006.01); A61K 31/167 (2006.01); A61K 9/00 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 15/08 (2006.01); A61K 47/34 (2017.01); A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61M 5/178 (2006.01); A61M 35/00 (2006.01); A61K 9/06 (2006.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/42 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0095 (2013.01); A61K 9/08 (2013.01); A61K 9/1611 (2013.01); A61K 9/1617 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/485 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/5031 (2013.01); A61K 31/167 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61K 47/36 (2013.01); A61K 47/38 (2013.01); A61M 5/178 (2013.01); A61M 35/00 (2013.01); A61P 15/08 (2018.01); A61K 9/06 (2013.01); A61M 25/00 (2013.01); A61M 2205/04 (2013.01); A61M 2210/04 (2013.01); A61M 2210/1017 (2013.01); A61M 2210/1021 (2013.01); A61M 2210/1425 (2013.01);
Abstract
A pharmaceutical composition for treating infertility in a female subject substantially consists of local anesthetic of amide type such as lidocaine, human albumin, viscosity controlling agent selected from recombinant hyaluronic acid and combination of recombinant hyaluronic acid and water-soluble cellulose ether, optionally citrate, glucose, and/or amino acid, water optionally comprising one or more ions selected from the group consisting of sodium, potassium, magnesium, calcium, acetate, chloride, sulfate. Also disclosed is a method of treating infertility by administration of the composition to a female subject in need thereof.